El Ouagari, Khalid <br/><br/>
Cost-effectiveness of letrozole in the extended adjuvant treatment of women with early breast cancer.  [electronic resource] 

 -  Breast cancer research and treatment  Jan 2007 
 - 37-49 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0167-6806 
<br/><br/><label>Standard No.: </label>10.1007/s10549-006-9262-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--economics<br/>Breast Neoplasms--drug therapy<br/>Chemotherapy, Adjuvant--economics<br/>Cost-Benefit Analysis<br/>Female<br/>Humans<br/>Letrozole<br/>Middle Aged<br/>Nitriles--economics<br/>Quality-Adjusted Life Years<br/>Tamoxifen--therapeutic use<br/>Treatment Outcome<br/>Triazoles--economics